To learn about the effectiveness of Nimbus against coronavirus, please contact us.


Whole Room Disinfection

The only patented hospital-grade surface disinfecting system approved for fogging EPA-Registered hypochlorous acid (HOCl).

Innovative disinfection, perfected.

2019 Novel Coronavirus (2019-nCoV)

Greater than 99.99% effective against viruses similar to
SARS-CoV-2 Coronavirus (COVID-19)

Nevoa® has created a no-touch, hospital disinfection product utilizing a unique hypochlorous acid solution that eliminates the human error associated with manual cleaning, and offers healthcare providers the ability to completely and confidently disinfect surfaces in their facilities.

Independent laboratory testing has proven the Nimbus + Microburst™ product disinfects viruses including Influenza-A (H1N1) and Feline Calicivirus (FCV), which are lab recommended viral surrogates for Coronavirus including SARS, MERS and SARS-CoV-2 (the virus which causes COVID-19 Disease). Disinfection results range from LOG 4.8 to LOG 5.4 (better than 99.99% effective in all cases).

Today, the recent Coronavirus outbreak has created tremendous awareness of the importance of disinfection. Nevoa’s technology is a game-changer for combatting deadly pathogens.

Click here to download facts about SARS-CoV-2 (aka COVID-19) from the Association for Professionals in Infection Control and Epidemiology (APIC).

Do No Harm

At Nevoa® we started with a simple idea... let’s innovate a better and more affordably accessible way to save lives through disinfection – giving the healthcare industry back their ability to “do no harm.”


Nevoa Inc.
1749 S. Holbrook Ln
Tempe, AZ 85281


Made in USA Made in USA

Let's Encrypt

© Nevoa Inc.

EPA Est. No. 86091-WI-1